Fig. 6From: Achievement of pathological complete response with osimertinib for EGFR-mutated lung adenocarcinomaPathological finding after osimertinib treatment. Pathological sections showed no viable tumor cells in any surgical specimen. Only extensive fibrosis with chronic inflammation was observedBack to article page